Inducible expression of FGF2 by a rat oligodendrocyte precursor cell line promotes CNS myelination in vitro

Experimental Neurology

Volumn 184, Issue 2, 2003, Pages 912-922

  Magy, Laurent ^a,b   Mertens, Caroline ^a   Avellana Adalid, Virginia ^a   Keita, Mahamane ^b   Lachapelle, François ^a   Nait Oumesmar, Brahim ^a   Fontaine, Bertrand ^a   Evercooren, Anne Baron Van ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Fibroblast growth factor 2; In vitro; Inducible expression; Myelination; Oligodendrocyte precursor

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; RECOMBINANT FIBROBLAST GROWTH FACTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE RELEASE; GENETIC ENGINEERING; GENETIC TRANSFECTION; IN VITRO STUDY; MYELINATION; NERVE FIBER; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL;

EID: 0842342524     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2003.08.019     Document Type: Article

References (38)

1. Armstrong R.C., Le T.Q., Frost E.E., Borke R.C., Vana A.C. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J. Neurosci. 22:2002;8574-8585.
2. Asakura K., Hunter S.F., Rodriguez M. Effects of transforming growth factor-beta and platelet-derived growth factor on oligodendrocyte precursors: insights gained from a neuronal cell line. J. Neurochem. 68:1997;2281-2290.
3. Avellana-Adalid V., Nait-Oumesmar B., Lachapelle F., Baron-Van Evercooren A. Expansion of rat oligodendrocyte progenitors into proliferative "oligospheres" that retain differentiation potential. J. Neurosci. Res. 45:1996;558-570.
4. Bansal R. Fibroblast growth factors and their receptors in oligodendrocyte development: implications for demyelination and remyelination. Dev. Neurosci. 24:2002;35-46.
5. Bansal R., Pfeiffer S.E. FGF-2 converts mature oligodendrocytes to a novel phenotype. J. Neurosci. Res. 50:1997;215-228.
6. Baron U., Freundlieb S., Gossen M., Bujard H. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res. 23:1995;3605-3606.
7. Baron W., de Jonge J.C., de Vries H., Hoekstra D. Perturbation of myelination by activation of distinct signaling pathways: an in vitro study in a myelinating culture derived from fetal rat brain. J. Neurosci. Res. 59:2000;74-85.
8. Baron-Van Evercooren A. Future prospects in transplantation. Ann. Neurol. 36 Suppl. 1994;S151-S156.
9. Bogler O., Wren D., Barnett S.C., Land H., Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 87:1990;6368-6372.
10. Boularand S., Darmon M.C., Ravassard P., Mallet J. Characterization of the human tryptophan hydroxylase gene promoter. Transcriptional regulation by cAMP requires a new motif distinct from the cAMP-responsive element. J. Biol. Chem. 270:1995;3757-3764.
11. Chang A., Nishiyama A., Peterson J., Prineas J., Trapp B.D. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J. Neurosci. 20:2000;6404-6412.
12. Chang A., Tourtellotte W.W., Rudick R., Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346:2002;165-173.
13. Decker L., Avellana-Adalid V., Nait-Oumesmar B., Durbec P., Baron-Van Evercooren A. Oligodendrocyte precursor migration and differentiation: combined effects of PSA residues, growth factors, and substrates. Mol. Cell. Neurosci. 16:2000;422-439.
14. Demerens C., Stankoff B., Logak M., Anglade P., Allinquant B., Couraud F.et al. Induction of myelination in the central nervous system by electrical activity. Proc. Natl. Acad. Sci. U. S. A. 93:1996;9887-9892.
15. Duncan I.D., Grever W.E., Zhang S.C. Repair of myelin disease: strategies and progress in animal models. Mol. Med. Today. 3:1997;554-561.
16. Eccleston P.A., Silberberg D.H. Fibroblast growth factor is a mitogen for oligodendrocytes in vitro. Brain Res. 353:1985;315-318.
17. Fressinaud C., Vallat J.M. Basic fibroblast growth factor improves recovery after chemically induced breakdown of myelin-like membranes in pure oligodendrocyte cultures. J. Neurosci. Res. 38:1994;202-213.
18. Fressinaud C., Vallat J.M., Labourdette G. Basic fibroblast growth factor down-regulates myelin basic protein gene expression and alters myelin compaction of mature oligodendrocytes in vitro. J. Neurosci. Res. 40:1995;285-293.
19. Frost E.E., Nielsen J.A., Le T.Q., Armstrong R.C. PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. J. Neurobiol. 54:2003;457-472.
20. Gard A.L., Pfeiffer S.E. Glial cell mitogens bFGF and PDGF differentially regulate development of O4+GalC- oligodendrocyte progenitors. Dev. Biol. 159:1993;618-630.
21. Goddard D.R., Berry M., Kirvell S.L., Butt A.M. Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo. Mol. Cell. Neurosci. 18:2001;557-569.
22. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U. S. A. 89:1992;5547-5551.
23. Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 268:1995;1766-1769.
24. Lachapelle F., Avellana-Adalid V., Nait-Oumesmar B., Baron-Van Evercooren A. Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol. Cell. Neurosci. 20:2002;390-403.
25. Lassmann H. Neuropathology in multiple sclerosis: new concepts. Mult. Scler. 4:1998;93-98.
26. Louis J.C., Magal E., Muir D., Manthorpe M., Varon S. CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J. Neurosci. Res. 31:1992;193-204.
27. Lubetzki C., Demerens C., Anglade P., Villarroya H., Frankfurter A., Lee V.M.et al. Even in culture, oligodendrocytes myelinate solely axons. Proc. Natl. Acad. Sci. U. S. A. 90:1993;6820-6824.
28. McKinnon R.D., Matsui T., Aranda M., Dubois-Dalcq M. A role for fibroblast growth factor in oligodendrocyte development. Ann. N. Y. Acad. Sci. 638:1991;378-386.
29. McKinnon R.D., Smith C., Behar T., Smith T., Dubois-Dalcq M. Distinct effects of bFGF and PDGF on oligodendrocyte progenitor cells. Glia. 7:1993;245-254.
30. Messersmith D.J., Murtie J.C., Le T.Q., Frost E.E., Armstrong R.C. Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J. Neurosci. Res. 62:2000;241-256.
31. Milner R., Anderson H.J., Rippon R.F., McKay J.S., Franklin R.J., Marchionni M.A.et al. Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration. Glia. 19:1997;85-90.
32. Ranscht B., Clapshaw P.A., Price J., Noble M., Seifert W. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc. Natl. Acad. Sci. U. S. A. 79:1982;2709-2713.
33. Ruffini F., Furlan R., Poliani P.L., Brambilla E., Marconi P.C., Bergami A.et al. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther. 8:2001;1207-1213.
34. Solly S.K., Daubas P., Monge M., Dautigny A., Zalc B. Functional analysis of the mouse myelin/oligodendrocyte glycoprotein gene promoter in the oligodendroglial CG4 cell line. J. Neurochem. 68:1997;1705-1711.
35. Sommer I., Schachner M. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev. Biol. 83:1981;311-327.
36. Tontsch U., Archer D.R., Dubois-Dalcq M., Duncan I.D. Transplantation of an oligodendrocyte cell line leading to extensive myelination. Proc. Natl. Acad. Sci. U. S. A. 91:1994;11616-11620.
37. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis [see comments]. N. Engl. J. Med. 338:1998;278-285.
38. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 18:1998;601-609.